Interplay of probiotics, prebiotics, synbiotics and postbiotics: a review of their therapeutic potential for gastrointestinal inflammation

Authors: Radhika Baheti, Sanjeevani Deshkar, Shivani Jadhav, Kanchan Mule, Abhishek Jha, Prabhanjan Giram, Jayashri Mahore

Journal: Food Research International

Year: 2026

Volume: 230

Article number: 118598

DOI: 10.1016/j.foodres.2026.118598


Study at a glance

  • Study type: Comprehensive review
  • Focus: Probiotics, prebiotics, synbiotics, postbiotics
  • Population studied: Patients with gastrointestinal inflammation, including irritable bowel syndrome, Crohn’s disease, and ulcerative colitis
  • Intervention categories: Dietary and supplemental interventions involving fermented foods, fibre-rich foods, and microbial metabolites
  • Primary outcomes: Effects on gut microbiota modulation, inflammatory markers, intestinal barrier integrity, and clinical symptoms

Why was this study done?

Many gut conditions are closely tied to the balance of bacteria living in the intestines. When that balance is thrown off, a state known as dysbiosis, it is linked to inflammatory bowel conditions such as Crohn’s disease and ulcerative colitis, as well as to irritable bowel syndrome.

Baheti and colleagues set out to pull together the current understanding of four related tools for keeping the gut healthy: prebiotics, probiotics, synbiotics, and postbiotics. Prebiotics are types of fibre we cannot digest ourselves but that feed the helpful bacteria in our gut. Probiotics are live “good” bacteria taken to benefit health. Synbiotics simply combine the two. Postbiotics are the useful substances those bacteria produce, including short-chain fatty acids, which help calm inflammation. The authors wanted to bring together recent laboratory and clinical research, explain how these tools work, and point out where the evidence is still thin.


How was the study performed?

The authors reviewed laboratory studies and clinical trials on prebiotics, probiotics, synbiotics, and postbiotics. They looked at how each one shifts the mix of gut bacteria, boosts the production of anti-inflammatory compounds, strengthens the gut lining, and helps steady the immune system.

They also drew together the everyday food sources of these substances, including fermented dairy such as yogurt and kefir, fermented vegetables such as kimchi and sauerkraut, and fibre-rich foods such as chicory root, onions, garlic, and whole grains, along with their potential role in gut inflammation.


What did the researchers find?

These tools appear to support gut health in several complementary ways. Prebiotics such as inulin-type fructans and galacto-oligosaccharides encourage helpful bacteria to grow. Those bacteria then ferment the prebiotics into short-chain fatty acids, which help dampen inflammation and keep the gut’s immune defences in balance.

Probiotics support the gut lining by tightening the seals between its cells, replacing harmful bacteria, and releasing substances that keep those harmful microbes in check. Their benefits are specific to each strain: in trials, different strains have been shown to shorten bouts of diarrhoea, help prevent the diarrhoea that can follow a course of antibiotics, and improve outcomes in ulcerative colitis and in pouchitis (inflammation of the internal pouch some people have after bowel surgery).

Synbiotics may do more than either component on its own, by helping the good bacteria survive and by supporting the production of health-promoting compounds.

Postbiotics, which include short-chain fatty acids, showed anti-inflammatory effects, helped protect the gut lining, and helped regulate the immune system. Because they contain no living bacteria, they may be a safer option for people who are more vulnerable, such as infants and those with weakened immune systems.

Overall, the clinical evidence points to a useful role for these approaches in gut inflammation, particularly in irritable bowel syndrome, Crohn’s disease, and ulcerative colitis, by helping to correct the bacterial imbalance and settle inflammation in the gut lining. The authors also noted that people respond quite differently to them, and that the field still needs agreed strains, clear dosing, and consistent regulation.


What did the authors conclude?

The authors concluded that prebiotics, probiotics, synbiotics, and postbiotics are a promising way to help manage gut inflammation, working together to improve the balance of gut bacteria, increase helpful compounds, strengthen the gut lining, and steady the immune response.

Real hurdles remain, though. People respond in different ways, there is no agreement yet on which strains and doses work best, and regulation across products is inconsistent.

Future research, they suggest, should focus on pinning down which bacterial strains actually help, working out the best doses and treatment lengths, and moving towards tailored approaches that match the treatment to a person’s own gut make-up and health needs.


Key takeaways

  • Prebiotics, probiotics, synbiotics, and postbiotics can support gut health together, by rebalancing gut bacteria, producing anti-inflammatory compounds, strengthening the gut lining, and helping regulate the immune system.
  • Clinical evidence backs their use in gut inflammatory conditions such as irritable bowel syndrome, Crohn’s disease, and ulcerative colitis, where they help correct bacterial imbalance and calm inflammation in the gut lining.
  • Probiotic benefits depend on the specific strain, with different strains shown to ease diarrhoea, help prevent antibiotic-related complications, and support remission in inflammatory bowel disease.
  • Postbiotics, the useful substances bacteria leave behind, may be a safer alternative to live probiotics for more vulnerable people while still offering benefits.
  • Important gaps remain, including how differently people respond, the lack of agreed strains and doses, and the absence of consistent regulation to guide everyday use.

This Scientific Publication Summary is an objective summary of the published study for personal and educational use. It does not constitute medical advice, endorsement of the intervention, or a recommendation to alter clinical practice.

For general information only. This article is for general information and is not a substitute for professional medical advice, diagnosis or treatment. It reflects the best available evidence at the time of writing and may not capture the most recent developments. Always talk to your GP, pharmacist or healthcare team before acting on anything you read here, and never disregard professional advice or delay seeking it because of something on this site. Where we mention products from Vance Medical Foods Ltd we identify this clearly.
Last updated 22 July 2026
×
×